A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies

Previous authors have proposed the sequential parallel comparison design (SPCD) to address the issue of high placebo response rate in clinical trials. The original use of SPCD focused on binary outcomes, but recent use has since been extended to continuous outcomes that arise more naturally in many fields, including psychiatry. Analytic methods proposed to date for analysis of SPCD trial continuous data included methods based on seemingly unrelated regression and ordinary least squares. Here, we propose a repeated measures linear model that uses all outcome data collected in the trial and accounts for data that are missing at random. An appropriate contrast formulated after the model has been fit can be used to test the primary hypothesis of no difference in treatment effects between study arms. Our extensive simulations show that when compared with the other methods, our approach preserves the type I error even for small sample sizes and offers adequate power and the smallest mean squared error under a wide variety of assumptions. We recommend consideration of our approach for analysis of data coming from SPCD trials.

[1]  R. Sysko,et al.  Placebo response in studies of major depression: variable, substantial, and growing. , 2002, JAMA.

[2]  David A. Schoenfeld,et al.  The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach , 2003, Psychotherapy and Psychosomatics.

[3]  Anastasia Ivanova,et al.  Optimality, sample size, and power calculations for the sequential parallel comparison design , 2011, Statistics in medicine.

[4]  Xiaohong Huang,et al.  Estimation of treatment effect for the sequential parallel design , 2011, Statistics in medicine.

[5]  M. Pencina,et al.  A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study) , 2012, Psychotherapy and Psychosomatics.

[6]  Xiaohong Huang,et al.  An examination of the efficiency of the sequential parallel design in psychiatric clinical trials , 2007, Clinical trials.

[7]  Yang Yang,et al.  Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials. , 2011, Contemporary clinical trials.

[8]  Joseph W Hogan,et al.  Handling drop‐out in longitudinal studies , 2004, Statistics in medicine.

[9]  R. Little,et al.  The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.

[10]  Roy N. Tamura,et al.  Comparison of Test Statistics for the Sequential Parallel Design , 2010 .

[11]  M. Trivedi,et al.  Does a Placebo Run-In or a Placebo Treatment Cell Affect the Efficacy of Antidepressant Medications? , 1994, Neuropsychopharmacology.